Birmingham, West Midlands -- (SBWIRE) -- 10/24/2013 -- Value Penny Stocks issues special report on The Cheesecake Factory Incorporated (NASDAQ:CAKE), Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), Generex Biotechnology Corporation (OTCMKTS:GNBT), Pitney Bowes Inc. (NYSE:PBI).
The Cheesecake Factory Incorporated (NASDAQ:CAKE) ended its recent business day with the loss of -1.56% and closed at the price of $42.81 after opening at $43.00. The stock traded during its last trading session with the total volume of 2,116,962 shares, as compared to its average volume of 654,938.00 shares. The Cheesecake Factory Incorporated owns and operates upscale, casual dining, full-service restaurants. As of October 2, 2013, the company operated 177 casual dining restaurants.
Has CAKE Found The Bottom and Ready To Move Up? Find Out Here
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) remained among the day decliners and traded with volume of 1,878,543 shares in the last session, as compared to average volume of 1.88 million shares. In comparison with 52 week range of $8.85 - $16.43, it faced lowest price of $14.39 during the last trading session whereas its day highest price was $14.72. The company’s total market capitalization is $2.57 billion, along with 178.06 million shares outstanding. Allscripts Healthcare Solutions, Inc. provides clinical, financial, connectivity, and information solutions and related professional services to hospitals, physicians, and post-acute organizations primarily in the United States and Canada.
Has MDRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) showed 1.87 million shares in volume during the last trading session, while the average trading volume remained 1.93 million shares. The stock kicked off its trading session at $0.03 and closed at $0.0305 after declining -3.79%. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
Pitney Bowes Inc. (NYSE:PBI) stock traded during its last trading session with the total traded volume of 1,873,960 shares versus its average volume of 3.48 million shares. The company opened its trade at the price of $19.94 and its closing price was $19.95 after losing -0.75% for the day. Pitney Bowes Inc. provides software, hardware, and services to enable physical and digital communications in the United States and internationally. It also offers a suite of equipment, supplies, software, services, and solutions for managing and integrating physical and digital communication channels.
Will PBI Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)